BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27647227)

  • 21. Liver enzyme levels and hepatic iron content in Fatty liver: a noninvasive assessment in general population by T2* mapping.
    Radmard AR; Poustchi H; Dadgostar M; Yoonessi A; Kooraki S; Jafari E; Hashemi Taheri AP; Malekzadeh R; Merat S
    Acad Radiol; 2015 Jun; 22(6):714-21. PubMed ID: 25754799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between ultrasound features of nonalcoholic fatty liver disease and cardiometabolic risk factors in patients with newly diagnosed type 2 diabetes.
    Kosmalski M; Kasznicki J; Drzewoski J
    Pol Arch Med Wewn; 2013; 123(9):436-42. PubMed ID: 23792440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Relationship Between Tamoxifen-associated Nonalcoholic Fatty Liver Disease and the Prognosis of Patients With Early-stage Breast Cancer.
    Yan M; Wang J; Xuan Q; Dong T; He J; Zhang Q
    Clin Breast Cancer; 2017 Jun; 17(3):195-203. PubMed ID: 28089627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modifiable clinical and lifestyle factors are associated with elevated alanine aminotransferase levels in newly diagnosed type 2 diabetes patients: results from the nationwide DD2 study.
    Mor A; Svensson E; Rungby J; Ulrichsen SP; Berencsi K; Nielsen JS; Stidsen JV; Friborg S; Brandslund I; Christiansen JS; Beck-Nielsen H; Sørensen HT; Thomsen RW
    Diabetes Metab Res Rev; 2014 Nov; 30(8):707-15. PubMed ID: 24639417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Female spontaneously diabetic Torii fatty rats develop nonalcoholic steatohepatitis-like hepatic lesions.
    Ishii Y; Motohashi Y; Muramatsu M; Katsuda Y; Miyajima K; Sasase T; Yamada T; Matsui T; Kume S; Ohta T
    World J Gastroenterol; 2015 Aug; 21(30):9067-78. PubMed ID: 26290633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease.
    Pais R; Rusu E; Zilisteanu D; Circiumaru A; Micu L; Voiculescu M; Poynard T; Ratziu V
    Eur J Intern Med; 2015 Jan; 26(1):30-6. PubMed ID: 25553983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease.
    Pacifico L; Bonci E; Di Martino M; Versacci P; Andreoli G; Silvestri LM; Chiesa C
    Nutr Metab Cardiovasc Dis; 2015 Aug; 25(8):734-41. PubMed ID: 26026214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and significance of fat mass and obesity associated gene and forkhead transcription factor O1 in non-alcoholic fatty liver disease.
    Zhang J; Li S; Li J; Han C; Wang Z; Li C; Wang X; Liu Z; Wen J; Zheng L
    Chin Med J (Engl); 2014; 127(21):3771-6. PubMed ID: 25382334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevalence of nonalcoholic fatty liver disease and metabolic abnormalities in 387 obese children and adolescents in Beijing, China].
    Zhou X; Hou DQ; Duan JL; Sun Y; Cheng H; Zhao XY; Liu JT; Yang P; Shan XY; Mi J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 May; 34(5):446-50. PubMed ID: 24016432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between obstructive sleep apnea and nonalcoholic fatty liver disease in nonobese adults.
    Qi JC; Huang JC; Lin QC; Zhao JM; Lin X; Chen LD; Huang JF; Chen X
    Sleep Breath; 2016 May; 20(2):529-35. PubMed ID: 26174847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonalcoholic fatty liver disease is associated with breast cancer in nonobese women.
    Kwak MS; Yim JY; Yi A; Chung GE; Yang JI; Kim D; Kim JS; Noh DY
    Dig Liver Dis; 2019 Jul; 51(7):1030-1035. PubMed ID: 30686716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shiftwork Is Not Associated with Increased Risk of NAFLD: Findings from the National Health and Nutrition Examination Survey.
    Balakrishnan M; El-Serag HB; Kanwal F; Thrift AP
    Dig Dis Sci; 2017 Feb; 62(2):526-533. PubMed ID: 27995401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevalence of nonalcoholic liver steatosis in patients with type 2 diabetes mellitus in the Czech Republic.
    Dvorak K; Hainer R; Petrtyl J; Zeman M; Vareka T; Zak A; Sroubkova R; Svestka T; Vitek L; Bruha R
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Sep; 159(3):442-8. PubMed ID: 25004910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-alcoholic fatty liver disease and its associated risk factors in Brazilian postmenopausal women.
    Bruno Ade S; Rodrigues MH; Alvares MC; Nahas-Neto J; Nahas EA
    Climacteric; 2014 Aug; 17(4):465-71. PubMed ID: 24517420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors.
    Koller T; Kollerova J; Hlavaty T; Huorka M; Payer J
    Scand J Gastroenterol; 2012 Feb; 47(2):197-203. PubMed ID: 22182015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of high sensitivity C-reaction protein in non-insulin dependent diabetes mellitus patients with non-alcoholic fatty liver disease.
    Bi Y; Min M; Shen W; Deng P; Du Q; Dong M; Liu Y
    Int J Clin Exp Pathol; 2015; 8(7):8494-9. PubMed ID: 26339423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-alcoholic fatty liver disease among sasang constitutional types: a population-based study in Korea.
    Lee SK; Yoon DW; Lee SW; Kim JY; Kim JK; Shin C
    BMC Complement Altern Med; 2015 Nov; 15():399. PubMed ID: 26547840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse impact of egg consumption on fatty liver is partially explained by cardiometabolic risk factors: A population-based study.
    Mazidi M; Mikhailidis DP; Banach M
    Clin Nutr; 2020 Dec; 39(12):3730-3735. PubMed ID: 32928581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-Alcoholic Fatty Liver Disease and Associated Factors among Type 2 Diabetic Patients in Southwest Ethiopia.
    Zawdie B; Tadesse S; Wolide AD; Nigatu TA; Bobasa EM
    Ethiop J Health Sci; 2018 Jan; 28(1):19-30. PubMed ID: 29622904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT).
    Kalra S; Vithalani M; Gulati G; Kulkarni CM; Kadam Y; Pallivathukkal J; Das B; Sahay R; Modi KD
    J Assoc Physicians India; 2013 Jul; 61(7):448-53. PubMed ID: 24772746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.